These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 2823620
1. Detection of early pregnancy factor-like activity in women with gestational trophoblastic tumors. Mehta AR, Shahani SK. Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):67-9. PubMed ID: 2823620 [Abstract] [Full Text] [Related]
2. Early pregnancy factor (EPF) as tumour marker in two patients with trophoblastic tumour. Bojahr B, Straube W, Römer T. Arch Gynecol Obstet; 1993 Jul; 252(4):215-8. PubMed ID: 8390229 [Abstract] [Full Text] [Related]
3. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease. Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K. Gynecol Obstet Invest; 1987 Jul; 23(3):151-6. PubMed ID: 3036671 [Abstract] [Full Text] [Related]
4. A study of early pregnancy factor activity in the sera of women with trophoblastic tumor. Fan X, Yan L, Jia S, Ma A, Qiao C. Am J Reprod Immunol; 1999 Mar; 41(3):204-8. PubMed ID: 10326623 [Abstract] [Full Text] [Related]
5. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease. Khoo SK, Daunter B. Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013 [Abstract] [Full Text] [Related]
7. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy. Goldstein DP. Am J Obstet Gynecol; 1971 Jun 15; 110(4):583-7. PubMed ID: 4325820 [No Abstract] [Full Text] [Related]
8. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases. Shaarawy M, Darwish NA, Abdel-Aziz O. J Soc Gynecol Investig; 1996 Jun 15; 3(1):39-46. PubMed ID: 8796806 [Abstract] [Full Text] [Related]
9. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm. Jones WB, Lehr M, Lewis JL. Surg Forum; 1973 Jun 15; 24():563-5. PubMed ID: 4377042 [No Abstract] [Full Text] [Related]
10. [Case observations on the significance of early pregnancy factor as a tumor marker]. Bojahr B, Straube W, Reddemann H. Zentralbl Gynakol; 1993 Jun 15; 115(3):125-8. PubMed ID: 7682025 [Abstract] [Full Text] [Related]
11. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Ozturk M, Berkowitz R, Goldstein D, Bellet D, Wands JR. Am J Obstet Gynecol; 1988 Jan 15; 158(1):193-8. PubMed ID: 2447774 [Abstract] [Full Text] [Related]
12. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease. Lösch A, Kainz C. Acta Obstet Gynecol Scand; 1996 Sep 15; 75(8):753-6. PubMed ID: 8906012 [Abstract] [Full Text] [Related]